Revolution Medicines (RVMD) Preferred Dividend Payments (2019 - 2020)
Revolution Medicines' (RVMD) quarterly Preferred Dividend Payments came in at $2.2 million in Q1 2020, down 17.08% year-on-year from $2.7 million in Q2 2019, and down 47.8% quarter-over-quarter from $4.3 million in Q4 2019.
Revolution Medicines (RVMD) Preferred Dividend Payments (2019 - 2020) Analysis & Trends
Revolution Medicines' Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $2.2 million for Q1 2020.
- On a quarterly basis, Preferred Dividend Payments fell 17.08% year-over-year to $2.2 million in Q1 2020; TTM through Dec 2020 was $2.2 million, a 84.41% decrease from a year earlier, with the FY2020 full-year figure at $2.2 million, down 84.41% from the prior year.
- Preferred Dividend Payments slipped to $2.2 million in Q1 2020 per RVMD's latest filing, from $4.3 million in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $4.3 million in Q4 2019 and bottomed at $2.2 million in Q1 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Alnylam Pharmaceuticals | 36.08 Bn | 33.07 Bn | 959.66 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 2.22 Mn |
| Dec 31, 2019 | 4.25 Mn |
| Sep 30, 2019 | 4.25 Mn |
| Jun 30, 2019 | 3.06 Mn |
| Mar 31, 2019 | 2.68 Mn |